AACR Foundation

10/27/2025

Michael Methner was diagnosed with a brain tumor at the age of 2. After years of grueling chemotherapy and other treatments, he and his parents are seeing progress with a new molecularly targeted therapy. Read his story: https://brnw.ch/21wWYC8

10/27/2025

COVID vaccines may improve immunotherapy effects, and a drug combination reduces the risk for death in bladder cancer.

10/26/2025

At the Rally for Medical Research, Richard Schlueter shared his story with Congress members and staff about the hope NIH provides patients like him and how budget cuts nearly took it away when his care was delayed. Learn more on the : https://brnw.ch/21wWWFX

10/25/2025

Everyone's experience with cancer is deeply personal. Whether you're a patient, survivor, caregiver, or loved one, your story can offer hope, inspiration, and strength to others facing similar challenges. Share your story today: https://brnw.ch/21wWVDO

10/24/2025

? Alcohol consumption increases the risk of six types of cancer, and emerging evidence indicates that there may be increased risks for additional malignancies. Learn more: https://brnw.ch/21wWUzC

10/24/2025

What is cancer research? Learn about the cycle of cancer research and the different areas of science, including basic, translational, clinical, and population research. https://brnw.ch/21wWUi4

10/24/2025

Thirty-three distinguished scientists whose major innovations have propelled progress against cancer were inducted as Fellows of the Academy at . Meet the 2025 class: https://brnw.ch/21wWT5a

10/23/2025

As people with advanced disease live longer, they face physical and mental health side effects. Patient advocates say research and care must focus on their unique needs. Cancer Today shares their unique perspective:

People with advanced cancer face long-term physical and mental side effects. Advocates say more research should focus on cancer survivorship.

10/23/2025

"We've realized HER2 is a spectrum rather than a binary value." Our fall issue explores how our understanding of HER2 status in breast cancer has changed with the use of targeted therapies that work even in cases with low HER2 expression.

Antibody-drug conjugate Enhertu provides an additional treatment option for people with HER2-low breast cancer.

10/23/2025

Small donations to the added up to something big for early-career researcher Madelyn Espinosa-Cotton, PhD. Learn how an AACR grant enabled her to study a rare and aggressive type of sarcoma. https://brnw.ch/21wWSgR

10/22/2025

Stay up-to-date on the recent approvals of products for cancer prevention, diagnosis, and treatment. Learn about the recent progress against cancer: https://brnw.ch/21wWR7E

10/22/2025

In the latest episode of Believe in Progress, Mitch talks with breast cancer survivors Patty Guthrie and Vicki Courlang about what they learned about cancer early detection, patient advocacy, and more. https://brnw.ch/21wWQWI ®